30,000 blood samples could revolutionize rapid disease testing
NCT ID NCT07378514
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allows doctors to test patients right at their bedside. The goal is to make monitoring health conditions quicker and easier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to faster, easier diagnostic tests that doctors can use right at the patient's bedside.
- What could go wrong
- This is a sample collection study, not a treatment trial. It is early-stage research focused on developing tests, so there is no direct benefit to participants and no guarantee the tests will work.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Could your bone health decide if a dental implant lasts?
- A new rice could tame blood sugar spikes in prediabetes
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?